annual EBITDA:
-$216.68M-$123.68M(-132.98%)Summary
- As of today (September 16, 2025), APGE annual EBITDA is -$216.68 million, with the most recent change of -$123.68 million (-132.98%) on December 31, 2024.
- During the last 3 years, APGE annual EBITDA has fallen by -$186.05 million (-607.30%).
- APGE annual EBITDA is now -607.30% below its all-time high of -$30.64 million, reached on December 31, 2022.
Performance
APGE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$72.77M-$9.88M(-15.70%)Summary
- As of today (September 16, 2025), APGE quarterly EBITDA is -$72.77 million, with the most recent change of -$9.88 million (-15.70%) on June 30, 2025.
- Over the past year, APGE quarterly EBITDA has dropped by -$28.68 million (-65.05%).
- APGE quarterly EBITDA is now -3906.88% below its all-time high of -$1.82 million, reached on June 1, 2022.
Performance
APGE quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$270.10M-$28.68M(-11.88%)Summary
- As of today (September 16, 2025), APGE TTM EBITDA is -$270.10 million, with the most recent change of -$28.68 million (-11.88%) on June 30, 2025.
- Over the past year, APGE TTM EBITDA has dropped by -$126.40 million (-87.96%).
- APGE TTM EBITDA is now -6174.03% below its all-time high of -$4.30 million, reached on March 1, 2022.
Performance
APGE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
APGE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -133.0% | -65.0% | -88.0% |
| 3 y3 years | -607.3% | -3906.9% | -4312.6% |
| 5 y5 years | -607.3% | -1590.2% | -6174.0% |
APGE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -607.3% | at low | -3906.9% | +4.0% | -4312.6% | at low |
| 5 y | 5-year | -607.3% | at low | -3906.9% | +4.0% | -6174.0% | at low |
| alltime | all time | -607.3% | at low | -3906.9% | +4.0% | -6174.0% | at low |
APGE EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$72.77M(+15.7%) | -$270.10M(+11.9%) |
| Mar 2025 | - | -$62.89M(-17.0%) | -$241.42M(+11.4%) |
| Dec 2024 | -$216.68M(+133.0%) | -$75.81M(+29.3%) | -$216.68M(+21.7%) |
| Sep 2024 | - | -$58.64M(+33.0%) | -$178.03M(+23.9%) |
| Jun 2024 | - | -$44.09M(+15.6%) | -$143.70M(+21.3%) |
| Mar 2024 | - | -$38.15M(+2.7%) | -$118.50M(+27.4%) |
| Dec 2023 | -$93.00M | -$37.16M(+52.9%) | -$93.00M(+66.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2023 | - | -$24.30M(+28.7%) | -$55.85M(+32.8%) |
| Jun 2023 | - | -$18.89M(+49.2%) | -$42.05M(+68.3%) |
| Mar 2023 | - | -$12.66M(+20.5%) | -$24.98M(+50.2%) |
| Dec 2022 | -$30.64M | - | - |
| Sep 2022 | - | -$10.51M(+478.6%) | -$16.63M(+171.7%) |
| Jun 2022 | - | -$1.82M(-57.8%) | -$6.12M(+42.2%) |
| Mar 2022 | - | -$4.30M | -$4.30M |
FAQ
- What is Apogee Therapeutics, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. annual EBITDA year-on-year change?
- What is Apogee Therapeutics, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Apogee Therapeutics, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Apogee Therapeutics, Inc.?
- What is Apogee Therapeutics, Inc. TTM EBITDA year-on-year change?
What is Apogee Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of APGE is -$216.68M
What is the all time high annual EBITDA for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high annual EBITDA is -$30.64M
What is Apogee Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, APGE annual EBITDA has changed by -$123.68M (-132.98%)
What is Apogee Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of APGE is -$72.77M
What is the all time high quarterly EBITDA for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high quarterly EBITDA is -$1.82M
What is Apogee Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, APGE quarterly EBITDA has changed by -$28.68M (-65.05%)
What is Apogee Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of APGE is -$270.10M
What is the all time high TTM EBITDA for Apogee Therapeutics, Inc.?
Apogee Therapeutics, Inc. all-time high TTM EBITDA is -$4.30M
What is Apogee Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, APGE TTM EBITDA has changed by -$126.40M (-87.96%)